What stops people with HIV adhering to long term antiretroviral therapy?
A new study published in AIDS Research and Therapy explores people’s reasons for non-adherence to ART through a cohort in Uganda. They find travel, stigma, poor adherence education, and alternative medicine to be prominent factors.Read more
Kimia Farma urged to reduce prices of HIV/AIDS medicines
INDONESIA – State-owned pharmaceutical companies — PT Kimia Farma and Indofarma Global — were encouraged to join a limited auction and reduce prices of medicines for HIV patients and people living with AIDS, an HIV/AIDS activist stated.Read more
Health workers may be giving you false HIV/Aids results
An audit report by the Office of the Auditor General of Global Fund covering 2016 and 2017 tells of massive irregular payment to workers and project activities.Read more
The long road to zero
A Bangkok symposium on HIV/Aids looks at the progress being made to turn the disease from “epidemic” to “endemic”Read more
Europe closer to biosimilar rule change, despite fierce resistance from pharma
The importance to follow the international debate on biosimilars is due to the expectations they would lead the way to the next generation of medicines to treat HIV/AidsRead more
Drug companies have overlooked patients who don’t respond to HIV meds
There are tens of thousands of these non-responders in the U.S., whose low CD4 numbers put them at much higher risk of heart attacks, stroke, cancers, secondary infections such as tuberculosis, and death. And yet, drug companies and researchers aren’t actively pursuing new treatments that would boost their immunity, leaving people like Vergel feeling neglected.Read more
ABIA concerned after the exoneration of HIV/AIDS and STIs Department Director
In view of recent changes in the Ministry of Health’s Department of Surveillance, Prevention and Control of STIs, HIV and Viral Hepatitis of the Ministry of Health, ABIA wishes to express concerns regarding the sustainability STIs and HIV/AIDS control policies.Read more
HIV in the Philippines: why it must act fast to control growing epidemic, advocacy groups lead the way
While many countries, including in Southeast Asia, have seen a fall in new HIV infections, the Philippines has seen a sharp rise.
Bureaucracy, a conservative society and the Catholic Church are the main stumbling blocks to effective action.
Elizabeth Warren is trying to break up Big Pharma “cartels” by letting the government make generic drugs
Democratic Sen. Elizabeth Warren, who’s widely expected to run for president in 2020, introduced a bold piece of legislation Tuesday that seeks to break up generic drug “cartels” by allowing the U.S. government to manufacture its own drugs.Read more
Gilead legal action blocks delivery of generic medicine for Hep C treatment in Brazil
Twelve trucks are stationed in the Ministry of Health’s warehouse, in Sao Paulo, with shipments that would allow for the treatment of 15,000 patients who have been waiting for these medicines for a year. The reason is that Gilead Sciences blocked the delivery of hep C treatment generic medicines, which were purchased on an emergency call for more severe patients. The Court upheld Gilead’s claim that the generic drug value is insufficient. Meanwhile, Gilead has already applied for the medicine’s patent.Read more